Media headlines about Neptune Technologies & Bioresources (NASDAQ:NEPT) (TSE:NTB) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neptune Technologies & Bioresources earned a news sentiment score of 0.02 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 47.1553843051953 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

Neptune Technologies & Bioresources (NASDAQ:NEPT) traded down 2.1718% on Monday, hitting $0.8108. 97,818 shares of the stock were exchanged. The company has a market cap of $63.71 million, a PE ratio of 12.4738 and a beta of 0.82. The company’s 50-day moving average is $0.85 and its 200-day moving average is $0.98. Neptune Technologies & Bioresources has a 52 week low of $0.80 and a 52 week high of $1.53.

TRADEMARK VIOLATION WARNING: “Neptune Technologies & Bioresources (NASDAQ:NEPT) Receives Daily Coverage Optimism Rating of 0.02” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.watchlistnews.com/neptune-technologies-bioresources-nasdaqnept-receives-daily-coverage-optimism-rating-of-0-02/1487234.html.

Neptune Technologies & Bioresources Company Profile

Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.

Receive News & Ratings for Neptune Technologies & Bioresources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioresources Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.